Roivant Sciences Ltd
ROIV
Market Cap$8.42B
Close$
$1.33
87.9% downside
Current Fair Value
87.9% downsideOvervalued by 87.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.42 Billion |
|---|---|
| Enterprise Value | $5.89 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $5.55 |
| Beta | 1.25 |
| Outstanding Shares | 735,816,536 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.77 |
|---|---|
| PEG | 4.83 |
| Price to Sales | - |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 77.33 |
| Enterprise Value to EBIT | -5.81 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data